Author
Listed:
- Michelle Schorer
(University of Zurich)
- Katharina Lambert
(University of Zurich
Benaroya Research Institute at Virginia Mason)
- Nikolas Rakebrandt
(University of Zurich)
- Felix Rost
(University of Zurich)
- Kung-Chi Kao
(University of Zurich)
- Alexander Yermanos
(ETH Zurich
D-BSSE, ETH Zurich)
- Roman Spörri
(ETH Zurich)
- Josua Oderbolz
(ETH Zurich)
- Miro E. Raeber
(University Hospital Zurich)
- Christian W. Keller
(University of Zurich
University Hospital Munster)
- Jan D. Lünemann
(University of Zurich
University Hospital Munster)
- Gerhard Rogler
(University Hospital Zurich)
- Onur Boyman
(University Hospital Zurich
University of Zurich)
- Annette Oxenius
(ETH Zurich)
- Nicole Joller
(University of Zurich)
Abstract
Foxp3+ regulatory T (Treg) cells are essential for maintaining peripheral tolerance and preventing autoimmunity. While genetic factors may predispose for autoimmunity, additional environmental triggers, such as viral infections, are usually required to initiate the onset of disease. Here, we show that viral infection with LCMV results in type I IFN-dependent Treg cell loss that is rapidly compensated by the conversion and expansion of Vβ5+ conventional T cells into iTreg cells. Using Vβ5-deficient mice, we show that these Vβ5+ iTreg cells are dispensable for limiting anti-viral immunity. Rather, the delayed replenishment of Treg cells in Vβ5-deficient mice compromises suppression of microbiota-dependent activation of CD8+ T cells, resulting in colitis. Importantly, recovery from clinical symptoms in IBD patients is marked by expansion of the corresponding Vβ2+ Treg population in humans. Collectively, we provide a link between a viral trigger and an impaired Treg cell compartment resulting in the initiation of immune pathology.
Suggested Citation
Michelle Schorer & Katharina Lambert & Nikolas Rakebrandt & Felix Rost & Kung-Chi Kao & Alexander Yermanos & Roman Spörri & Josua Oderbolz & Miro E. Raeber & Christian W. Keller & Jan D. Lünemann & Ge, 2020.
"Rapid expansion of Treg cells protects from collateral colitis following a viral trigger,"
Nature Communications, Nature, vol. 11(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15309-6
DOI: 10.1038/s41467-020-15309-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15309-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.